These results imply that one physiological function of melatonin‐induced HAS3 expression is to diminish the initiation of neuroblastoma cell formation via the binding of HA to the CD44 receptor and the induction of cancer cell differentiation. The gene discussed is HAS3; the disease is neuroblastoma.